PubRank

S B Harris

Author PubWeight™ 74.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes. Int J Obes Relat Metab Disord 2004 2.54
2 Use of ethnographic methods for applied research on diabetes among the Ojibway-Cree in northern Ontario. Health Educ Q 1996 2.16
3 A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet Med 2006 2.15
4 Overweight among children and adolescents in a Native Canadian community: prevalence and associated factors. Am J Clin Nutr 2000 1.76
5 The rupture rate of acute flexor tendon repairs mobilized by the controlled active motion regimen. J Hand Surg Br 1994 1.60
6 Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care 1997 1.55
7 Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr 1998 1.53
8 The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 1999 1.50
9 The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc Natl Acad Sci U S A 1992 1.45
10 Process evaluation of a multi-institutional community-based program for diabetes prevention among First Nations. Health Educ Res 2007 1.39
11 Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol 2000 1.27
12 Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 1999 1.26
13 Maternal nutritional status, diabetes and risk of macrosomia among Native Canadian women. Early Hum Dev 1998 1.23
14 Body image concepts differ by age and sex in an Ojibway-Cree community in Canada. J Nutr 1996 1.22
15 Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care 2001 1.20
16 The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree. Arterioscler Thromb Vasc Biol 2000 1.16
17 Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers. J Hum Genet 1999 1.14
18 Vitrification enhancement by synthetic ice blocking agents. Cryobiology 2000 1.10
19 Prevalence of anemia in First Nations children of northwestern Ontario. Can Fam Physician 1997 1.06
20 Dietary restriction and aging: historical phases, mechanisms and current directions. J Nutr 1987 1.06
21 Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes (Lond) 2006 1.03
22 Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes Relat Metab Disord 2003 1.01
23 Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997 1.00
24 Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 2000 1.00
25 Development of an integrated diabetes prevention program with First Nations in Canada. Health Promot Int 2006 1.00
26 Partners for life: the transfusion program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia. Immunohematology 2006 0.98
27 Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population. Int J Obes (Lond) 2006 0.97
28 Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree. Diabetes Care 2001 0.96
29 Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 2001 0.93
30 Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. Arterioscler Thromb Vasc Biol 1997 0.93
31 Variation in the AU(AT)-rich element within the 3'-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians. J Clin Endocrinol Metab 1998 0.92
32 Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial. Diabetes Obes Metab 2006 0.92
33 Primary prevention of type 2 diabetes in high-risk populations. Diabetes Care 2000 0.91
34 Association of a single nucleotide polymorphism in CPB2 encoding the thrombin-activable fibrinolysis inhibitor (TAF1) with blood pressure. Clin Genet 2001 0.90
35 A comparison of dynamic extension splinting and controlled active mobilization of complete divisions of extensor tendons in zones 5 and 6. J Hand Surg Br 2000 0.88
36 Elevated C-reactive protein in Native Canadian children: an ominous early complication of childhood obesity. Diabetes Obes Metab 2006 0.88
37 Low dietary fiber and high protein intakes associated with newly diagnosed diabetes in a remote aboriginal community. Am J Clin Nutr 1997 0.88
38 Two-generation reproduction study in rats given di-isononyl phthalate in the diet. Reprod Toxicol 2000 0.87
39 Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Diabetes Obes Metab 2011 0.86
40 The significance of extensor tendon tethering and dorsal joint capsule tightening after injury to the hand. J Hand Surg Br 2005 0.85
41 The results of immediate re-repair of zone 1 and 2 primary flexor tendon repairs which rupture. J Hand Surg Br 2006 0.85
42 Correlation of cytotoxicity and mitotic spindle dissolution by vinblastine in mammalian cells. Cancer Res 1977 0.84
43 G protein beta3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension 1998 0.83
44 Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 1996 0.83
45 Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations. Clin Chem Lab Med 2000 0.83
46 Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk. Diabetes Obes Metab 2012 0.83
47 Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes. Diabetes Care 1999 0.82
48 Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiol Genomics 2000 0.82
49 Reproductive and teratogenic effects of nitrous oxide, halothane, isoflurane, and enflurane in Sprague-Dawley rats. Anesthesiology 1986 0.82
50 Absence of association between genetic variation of the beta 3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care 1998 0.82
51 Teratology and percutaneous toxicity studies on hair dyes. J Toxicol Environ Health 1976 0.81
52 Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care 2000 0.81
53 Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree. Int J Obes Relat Metab Disord 2000 0.81
54 Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree. Clin Genet 1998 0.80
55 Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 1999 0.80
56 Insulin resistance in latent autoimmune diabetes of adulthood. Ann N Y Acad Sci 2003 0.80
57 Increased rates of adverse outcomes for gestational diabetes and pre-pregnancy diabetes in on-reserve First Nations Women in Ontario, Canada. Diabet Med 2012 0.79
58 Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 1997 0.79
59 Embryotoxicity of methyl mercuric chloride in golden hamsters. Teratology 1972 0.79
60 A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care. Diabetes Obes Metab 2013 0.79
61 Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 1997 0.78
62 Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes. Clin Biochem 1999 0.78
63 Developmental toxicity of di-isodecyl and di-isononyl phthalates in rats. Reprod Toxicol 1999 0.78
64 Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition. Diabetes Care 2001 0.77
65 NAT2 polymorphism associated with plasma glucose concentration in Canadian Oji-Cree. Pharmacogenetics 2000 0.77
66 Influence of intrauterine position on fetal weight in Dutch belted rabbits. J Toxicol Environ Health 1982 0.77
67 Risk of clinical diabetes in a northern Native Canadian cohort. Arctic Med Res 1994 0.77
68 Inhalation two-generation reproductive toxicity study of methyl isobutyl ketone in rats. Int J Toxicol 2004 0.77
69 -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. J Hum Genet 1998 0.76
70 Lack of effect of age and dietary restriction on DNA single-stranded breaks in brain, liver, and kidney of (C3H x C57BL/10)F1 mice. J Gerontol 1991 0.76
71 Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes. Lancet 1997 0.76
72 The ADD1 G460W polymorphism is not associated with variation in blood pressure in Canadian Oji-Cree. J Hum Genet 1999 0.76
73 Taking on diabetes. Family doctors on the front lines of the battle against diabetes. Can Fam Physician 1998 0.75
74 Factor V Leiden (F5 Q506) and vascular disease in Canadian Oji-Cree. Diabetes Care 1998 0.75
75 Hemochromatosis and diabetes mellitus. Ann Intern Med 1998 0.75
76 Evaluation of the Upj:TUC(ICR) strain of mice for use in teratology tests. J Toxicol Environ Health 1980 0.75
77 Application of the revised American Diabetes Association criteria for the diagnosis of diabetes in a Canadian Native population. Diabetes Care 1998 0.75
78 Fetal effects of inhalation exposure to cyclohexanone vapor in pregnant rats. Toxicol Ind Health 1989 0.75
79 Immediate repair and early mobilization of the extensor pollicis longus tendon in zones 1 to 4. J Hand Surg Br 2004 0.75
80 Preclinical safety evaluation of 15[S]15-methyl prostaglandin F2alpha : reproduction and teratology. Adv Prostaglandin Thromboxane Res 1978 0.75
81 Methylene tetrahydrofolate reductase gene, dietary folate, NIDDM, and atherosclerosis in Canadian Oji-Cree. Diabetes Care 1998 0.75
82 Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. Diabetes Care 1999 0.75
83 Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitus. Clin Biochem 1999 0.75
84 Conjoined twins (cephalothoracopagus) in a Charles River CD rat. Vet Pathol 1977 0.75
85 Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes. Diabet Med 2005 0.75
86 Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree. J Hum Genet 2000 0.75
87 Association between AGT codon 235 polymorphism and variation in serum concentrations of creatinine and urea in Canadian Oji-Cree. Clin Genet 1999 0.75